Keywords
How to Cite
Abstract
Обзор литературы посвящен современным представлениям о роли стволовых клеток в канцерогенезе, метастазировании злокачественных опухолей.References
Пожарисский К.М. Опухоли кишечника, индуцированные у крыс 1,2 — диметилгидразином // Вопр. онкол. — 1972. — Т.1 8. — №1. — С. 64-71.
Пожарисский К.М. Экспериментальный анализ морфогенеза и патогенеза эпителиальных опухолей кишечника // Автореф. дисс. докт. мед. наук. — Л. — 1978. — 27 с.
Пожарисский К.М., Климашевский В.Ф., Гущин В.А. Изменения кинетики популяций энтероцитов в процессе развития опухолей кишечника у крыс // Цитология. — 1977. — №7. — С. 768-780.
Al-Hajj M., Wicha M.S., Benito-Hernandez A. et al. Prospective identification of tumorigenic breast cancer cells // Proc Natl Acad Sci USA. — 2003. — Vol. 100. — P. 3983-3988.
Andre F., Cabioglu N., Assi H., Sabourin J.C. Expression of chemokine receptors predicts the site of metastatic relapse in patients with axillary node positive primary breast cancer // Ann. Oncol. — 2006. — Vol. 17. — P 945-951.
Ara T., Nakamura Y, Egawa T. et al. Impaired colonization of the gonads by primordial germ cells in mice lacking a chemokine stromal cell-derived factor-1 (SDF-1) // Proc Natl Acad Sci USA. — 2003. — Vol. 100. — P 53195323.
Arya M., Ahmed H., Silhi N. et al. Clinical importance and therapeutic implications of the pivotal CXCL12-CXCR4 (chemokine ligand-receptor) interaction in cancer cell migration // Tumour Biol. — 2007. — Vol. 28. — P. 123-131.
Baggiolini M. Chemokines and leukocyte traffic // Nature. — 1998. — Vol. 392. — P. 565-568.
Bagri A., Gurney T., He X. et al. The chemokine SDF-1 regulates migration of dentate granule cells // Development. — 2002. — Vol. 129. — P 4249-4260.
Barr F.G. Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma // Oncogene. — 2001. — Vol. 20. — P. 5736-5746.
Ben-Baruch A. Organ selectivity in metastasis: regulation by chemokines and their receptors // Clin. Exp Metastasis. — 2008. — Vol. 25. — P. 345-56.
Choi A.R., Park J.R., Kim R.J. et al. Inhibition of Wnt1 expression reduces the enrichment of cancer stem cells in a mouse model of breast cancer // Biochem Biophys Res Commun. — 2012. — Vol. 425. — P. 436-442.
Collins A.T., Berry P.A., Hyde C. et al. Prospective identification of tumorigenic prostate cancer stem cells // Cancer Res. — 2005. — Vol. 65. — P. 10946-10951.
Crane I.J., Wallace C.A., McKillop-Smith S. et al. CXCR4 receptor expression on human retinal pigment epithelial cells from blood-retina barrier leads to chemokine secretion and migration in response to stromal cell-derived factor // J. Immunol. — 2000. — Vol. 165. — P. 4372-4378.
Curnow S.J., Wloka K., Faint J.M. et al. Topical glucocorticoid therapy directly induces up-regulation of functional CXCR4 on primed T lymphocytes in the aqueous humor of patients with uveitis // J Immunol. — 2004. — Vol. 172. — P. 7154-7161.
Damas J.K., Eiken H.G., Oie E. et al. Myocardial expression of CC- and CXC-chemokines and their receptors in human end-stage heart failure // Cardiovasc Res. — 2000. — Vol. 47. — P. 778-787.
DeVita V.T., Hellman S., Rosenberg S.A. Cancer: Principles and Practice of Oncology — 6th ed. Philadelphia, PA: Lippincott Williams & Wilkins — 2001. — P 3056.
Dontu G., Al-Hajj M., Abdallah W.M. et al. Stem cells in normal breast development and breast cancer // Cell Proliferat. — 2003. — Vol. 36. — P. 59-72.
Fabrice A., Weiya X., Conforti R. et al. CXCR4 expression in early breast cancer and risk of distant recurrence // Oncologist. — 2009. — Vol. 14. — P. 1182-1188.
Fang D., Nguyen T.K., Leishear K. et al. A tumorigenic subpopulation with stem cell properties in melanomas // Cancer Res. — 2005. — Vol. 65. — P. 9328-9337.
Foreman K.E., Rizzo P., Osipo C., Miele L. The cancer stem cell hypothesis // Cancer Drug Discovery and Development: Stem Cells and Cancer / Eds. R.G. Bagley, B.A. Teicher — Springer Dordrecht. — 2009. — P. 3-14.
Ghods A.J., Irvin D., Liu G. et al. Spheres isolated from 9L gliosarcoma rat cell line possess chemoresistant and aggressive cancer stem-like cells // Stem Cells. — 2007. — Vol. 25. — P. 1645-1653.
Ginestier C., Hur M.H., Charafe-Jauffret E. et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome // Cell Stem Cell — 2007. — Vol. 1. — P. 555-567.
Haraguchi N., Utsunomiya T., Inoue H. et al. Characterization of a side population of cancer cells from human gastrointestinal system // Stem Cells. — 2006. — Vol. 24. — P. 506-513.
Hashimoto K., Shimizu C., Tsuda H. et al. Immunohisto-chemical detection of breast cancer stem cells in hormone receptor-positive breast cancer and their role in response to endocrine therapy and clinical outcome // Oncology. -2012. — Vol. 82. — P. 168-174.
Helbig G., Christopherson K.W., Bhat-Nakshatri P. et al. NF-kB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4 // J Biol Chem. — 2003. — Vol. 278. — P. 21631-21638.
Jordan N.J., Kolios G., Abbot S.E. et al. Expression of functional CXCR4 chemokine receptors on human colonic epithelial cells // J. Clin. Invest. — 1999. — Vol. 104. — P. 1061-1069.
Keane M.P, Arenberg D.A., Moore B.B. et al. CXC che-mokines and angiogenesis/angiostasis // Proc. Nat. Acad. Science USA. — 1998. — Vol. 110. — P. 288-296.
Koizumi K., Hojo S., Akashi T. et al. Chemokine receptors in cancer metastasis and cancer cell-derived chemokines in host immune response // Cancer Science. — 2007. — Vol. 98. — P. 1652-1658.
Kucia M., Dawn B., Hunt G. et al. Cells expressing early cardiac markers reside in the bone marrow and are mobilized into the peripheral blood after myocardial infarction // Circulat Res. — 2004. — Vol. 95. — P. 1191-1199.
Kucia M., Reca R., Miekus K. et al. Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis // Stem Cells. — 2005. — Vol. 23. — P 879-894.
Kwong J., Kulbe H., Wong D. et al. An antagonist of the chemokine receptor CXCR4 induces mitotic catastrophe in ovarian cancer cells // Mol Cancer Therapy. — 2009. — Vol. 8. — P. 1893-1905.
Lazarini F., Tham T.N., Casanova P et al. Role of the alpha-chemokine stromal cell-derived factor (SDF-1) in the developing and mature central nervous system // Glia. — 2003. — Vol. 42. — P. 139-148.
Li C., Heidt D.G., Dalerba P. et al. Identification of pancreatic cancer stem cells // Cancer Res. — 2007. — Vol. 67. — P. 1030-1037.
Libura J., Drukala J., Majka M. et al. CXCR4-SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and adhesion // Blood. — 2002. — Vol. 100. — P. 2597-2606.
Liu G., Yuan X., Zeng Z. et al. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma // Mol Cancer. — 2006. — Vol. 5. — P. 67-71.
Liu Y, Ji R., Li J. et al. Correlation effect of EGFR and CXCR4 and CCR7 chemokine receptors in predicting breast cancer metastasis and prognosis // J Exper Clin Cancer Res. — 2010. — Vol. 29. — P. 16-23.
Luster A.D. Chemokines: chemotactic cytokines that mediate inflammation. // New Engl. J. Med. — 1998. — Vol. 338. — P. 436-445.
Matsui W., Huff C.A., Wang Q. et al. Characterization of clonogenic multiple myeloma cells // Blood. — 2004. — Vol. 103. — P. 2332-2336.
Morimoto K., Kim S.J., Tanei T. et al. Stem cell marker aldehyde dehydrogenase 1-positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression // Cancer Sci. — 2009. — Vol. 100. — P. 1062-1068.
Murphy P.M. International Union of Pharmacology. XXX. Update on chemokine receptor nomenclature // Pharmacol. Revision. — 2002. — Vol. 54. — P. 227-229.
Murphy P.M. The molecular biology of leukocyte che-moattractant receptors // Ann. Review Immunology. — 1994. — Vol. 12. — P. 593-633.
Murphy P.M., Baggiolini M., Charo I.F. et al. International Union of Pharmacology. XXII. Nomenclature for chemo-kine receptors // Pharmacol. Rev. — 2000. — Vol. 52. — P. 145-176.
Okuda K., Sasaki H., Dumontet C. et al. Expression of excision repair cross-complementation group 1 and class completely resected non-small cell lung cancer // Lung Cancer. — 2008. — Vol. 62. — P. 105-112.
Paget S. The distribution of secondary growths in cancer of the breast // Lancet. — 1889. — Vol. 1. — P. 99-101.
Peichev M., Naiyer A.J., Pereira D. et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells idetifies a population of functional endothelial precursors // Blood. — 2000. — Vol. 95. — P. 952-958.
Petit I., Szyper-Kravitz M., Nagler A. et al. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4 // Natl. Immunol. — 2002. — Vol. 3. — P. 687-694.
Phillips R.J., Burdick M.D., Lutz M. et al. The Stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases / // Amer. J. Resp and Crit Care Med. — 2003. — Vol. 167. — P. 1676-1686.
Power C.A., Wells T.N. Cloning and characterization of human chemokine receptors // Trends Pharmac Sci. — 1996. — Vol. 17. — P. 209-213.
Pozharisski K.M. The significance of nonspecific injury for colon carcinogenesis in rats // Cancer Res. — 1975. — Vol. 35. — P. 3824-3830.75.
Pozharisski K.M. Morphology and morphogenesis of experimental epithelial tumors of the intestine // J. Natl. Canc. Inst. — 1975. — Vol. 54. — P 1115-1135.76.
Pozharisski K.M., Klimashevski V.F., Gushchin V.A. Study of kinetics of epithelial cell populations in normal tissues of the rat’s intestines and in carcinogenesis // Exp. Path. — 1980. — Vol. 18. — P. 387-413.74.
Premack B.A., Schall. Chemokine receptors: gateways to inflammation and infection // Nat. Med. — 1996. — Vol. 2. — P. 1174-1178.
Ptasznik A., Urbanowska E., Chinta S. et al. Crosstalk between BCR/ABL oncoprotein and CXCR4 signaling through a Src family kinase in human leukemia cells // J Exp Med. — 2002. — Vol. 196 — P. 667-678.
Ratajczak M.Z., Kucia M., Reca R. et al. Stem cell plasticity revisited: CXCR4-positive cells expressing mRNA for early muscle, liver and neural cells «hide out» in the bone marrow // Leukemia. — 2004. — Vol. 18. — P. 29-40.
Reca R., Jankowski K., Przybylski G. et al. CXCR4 is a PAX family transcription factor regulated gene // Blood. — 2004. — Vol. 104. — P. 3521-3527.
Rossi D., Zlotnik A. The biology of chemokines and their receptors // Ann Review Immun. — 2000. — Vol. 18. — P. 217-242.
Schioppa T., Uranchimeg B., Saccani A. et al. Regulation of the chemokine receptor CXCR4 by hypoxia // J Exp Med. — 2003. — Vol. 198. — P 1391-1402.
Singh S., Bond V.C., Powell M. et al. CXCR4-gp120-IIIB interactions induce caspase-mediated apoptosis of prostate cancer cells and inhibit tumor growth // Mol Cancer Ther. — 2009. — Vol. 8 — P. 178-184.
Singh S.K., Hawkins C., Clarke I.D. et al. Identification of human brain tumour initiating cells // Nature. — 2004. — Vol. 432. — P. 396-401.
Spano J.P, Andre F., Morat L. et al. Chemokine receptor CXCR4 and early-stage non-small cell lung cancer: pattern of expression and correlation with outcome // Ann Oncol. — 2008. — Vol. 15. — P. 613-617.
Tanei T., Morimoto K., Shimazu K. et al. Association of breast cancer stem cells identified by aldehyde de hydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers // Clin Cancer Res. — 2009. — Vol. 15. — P. 4234-4241.
Tomescu O., Xia S.J., Strezlecki D. et al. Inducible shortterm and stable long-term cell culture systems reveal that the PAX3-FKHR fusion oncoprotein regulates CXCR4, PAX3, and PAX7 expression // Lab Invest. — 2004. — Vol. 84. — P. 1060-1070.
Visvader J.E., Lindeman G.J. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions // Nat Rev Cancer. — 2008. — Vol. 8. — P. 755-768.
Wagner P.L., Hyjek E., Vazquez F.M. et al. CXCL12 and CXCR4 in adenocarcinoma of the lung: Association with metastasis and survival // J Thor Cardiovascular Surg. — 2009. — Vol. 137. — P. 615-621.
Wojakowski W., Tendera M., Michalowska A. et al. Mobilization of CD34/CXCR4+, CD34/CD117+, c-met+ stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction // Circulation. — 2004. — Vol. 110. — P. 3213-3220.
Yamaguchi J., Kusano K.F, Masuo O. et al. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization // Circulation. — 2003. — Vol. 107. — P. 1322-1328.
Zlotnik A. Chemokines and cancer // Int J Cancer. — 2006. — Vol. 119. — P. 2026-2029.
Zlotnik A. Involvement of chemokine receptors in organ-specific metastasis // Contrib Microbiol. — 2006. — Vol. 13. — P. 191-199.
Zou Y, Kottmann A.H., Kuroda M. et al. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development // Nature. — 1998. — Vol. 393. — P. 595-599.
Zushi Y, Noguchi K., Hashitani S. et al. Relations among expression of CXCR4, histological patterns, and metastatic potential in adenoid cystic carcinoma of the head and neck // Inter J Oncol. — 2008. — Vol. 33. — P. 11331139.
Lindsell C.E., Shawber C.J., Boulter J., Weinmaster G.(1995). Jagged: a mammalian ligand that activates Notch1 // Cell. — Vol. 80 (6). — P. 909-910.
Takebe N., Harris P.J., Warren R.Q., Ivy S.P. Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways. // Nat Rev Clin Oncol. — 2011 — Vol. 8 (2) — P. 97-106.
All the Copyright statements for authors are present in the standart Publishing Agreement (Public Offer) to Publish an Article in an Academic Periodical 'Problems in oncology' ...